InfuSystem signs new CEO employment agreement with Carrie Lachance; $500K base, 200K PSUs, 128K options

InfuSystem Holdings, Inc

Base salary $500,000; annual bonus up to 100% of base based on performance targets set by Compensation Committee.
Grant of 200,000 performance-based restricted stock units (PSUs) with vesting tied to stock price targets through 2028.
Grant of 128,000 stock options vesting 25% per year over 4 years.
Severance: 12 months salary on involuntary termination; 18 months on change-of-control termination.
CEO transition from President/COO to President/CEO effective May 19, 2025; agreement dated May 29, 2025.

item 3.03item 5.03item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Carrie Lachance

President and Chief Executive Officer

INFU · InfuSystem Holdings, Inc

Effective: 2025-05-19
Filed: Jun 03, 2025 23:59 UTC

The Second Amended Agreement reflects changes in Ms. Lachance’s compensation and other terms of employment in connection with her previously announced transition from President and Chief Operating Officer of the Company to President and Chief Executive Officer of the Company that occurred on May 19, 2025.

Source: SEC EDGAR

accession 0001628280-25-029052

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.